This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Findings from a collection of posters at ACCP underscore the critical role of communitypharmacies in promoting health equity and providing high-quality, patient-centered care.
A panel discussion at the Outcomes 2024 SYNC National Conference touched upon many important themes in communitypharmacy, including the evolving role of pharmacists, emerging tech, and key challenges going forward.
Progress on Government commitments to support both hospital and communitypharmacy services in England ‘require improvement’, an expert panel commissioned by the parliamentary Health and Social Care Committee has found.
The role of communitypharmacies has seen significant shifts in recent years prompting a need for a proactive approach to meet evolving patient expectations. Recognizing and addressing these changing dynamics is crucial as we step into 2024. One of the major drawbacks of digital pharmacy is the lack of face-to-face interactions.
Under the proposals registered pharmacy technicians could also take primary responsibility for the preparation and assembly of medicinal products in hospital aseptic facilities, and in doing so, supervise non-registered members of staff. The online consultation survey on pharmacy supervision is open until 29 February 2024.
We also highlight our members' perspectives on expanded pharmacy services, social determinants of health and access to care through communitypharmacy. Supporting Health Equity and Access to Care McKesson's Niki Shah discussed initiatives to support health equity through communitypharmacies. Register here!
Its most recent workforce wellbeing survey also revealed that inadequate staffing was affecting wellbeing for 70% of pharmacy professionals, with just 35% of pharmacists able to take their breaks. How representative was the 2024 RPS wellbeing survey? And just 34% of pharmacists reported enjoying their work down from 52% last year.
PQA is working with its members and the broader medication therapy management (MTM) community to build consensus on the research, measurement and strategies needed to evolve our national approach to evaluating MTM service quality. PQA invites your comments on a draft call to action through Friday, January 12, 2024, at 11:59 p.m.
Have you made your plans to join us at the 2024 PQA Annual Meeting, May 14-16, in Baltimore? Evaluating CommunityPharmacy Quality The CommunityPharmacy Enhanced Service Network (CPESN) special purpose network, CPESN Health Equity, is currently using the Choose My Pharmacy system across their entire membership.
When it came to hospital pharmacy in particular, the RPS highlighted the continuation of the Hospital Pharmacy Transformation programme and positive developments relating to aseptic services. Investment in aseptic services and development of hub sites has made steady progress to allow ‘spades in the ground’ in 2024,’ the report said.
Offering Resources to Implement Point-of-Care Testing The National Community Pharmacists Association and National Alliance of State Pharmacy Associations have developed a new guidance document to help communitypharmacy teams with their point-of-care testing services. "A prior to the PQA Leadership Summit.
The majority of respondents practiced in communitypharmacy (38%) and hospital pharmacy (28%) settings, with other represented pharmacy sectors including general practice (12%), academia or education bodies (5%), commissioning organisations (4%), and mental health services (3%).
-- Melissa Viscovich, PQA Chief Operating Officer Leveraging Trust to Improve Health Equity Outcomes A recent RxE2-sponsored pilot project sought to understand the feasibility of documenting health-related patient race and ethnicity information at the communitypharmacy. Learn more in the Member Resources Library.
The 2024 PQA Annual Meeting is less than six weeks away, and we are excited to welcome you all back to Baltimore! Addressing Pharmacy Deserts McKesson is launching Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities. Don't miss out! Register today!
In fact, prices can vary by hundreds of dollars between pharmacies—even when they are in the same town, according to a Consumer Reports survey. A study published in 2022 found “significant price variation in communitypharmacies.”
The Royal Pharmaceutical Society (RPS) is seeking feedback from hospital pharmacists on its green guide to making professional pharmacy practice more environmentally sustainable. To support the documents, in spring 2024 the RPS will launch a Greener Pharmacy Toolkit, allowing pharmacies to self-accredit their sustainability status.
For instance, the report, ‘ Tackling Antimicrobial Resistance 2019-2024 ‘ set a target to reduce UK antimicrobial use in humans by 15% by 2024. Consequently, attempts to increase antibiotic use – as with the pharmacy trimethoprim scheme – would not only thwart this target but potentially increase antimicrobial resistance.
A new standardised Medical Licensing Assessment (MLA) is set to be introduced in 2024, and will be required for all UK and international medical graduates. A communitypharmacy survey undertaken in 2021/22 found that community pharmacists contacted prescribers to discuss 1.3% of antibiotics prescriptions issued.
The guide was designed to spark conversation and foster collaboration between communitypharmacy organizations, pharmacists and health care payers. Loren Kirk, PQA’s Senior Director of Strategic Partnerships, managed the task force and development of the action guide.
The conversation highlights the importance of community partnerships and innovative approaches to bridging the gap between research and the community. The project is a pilot credentialing program for community pharmacists that aims to increase access to CGM and improve diabetes care.
A barrier to successful dispensing is poor communication between pharmacies and patients to identify social needs and health disparities. The CommunityPharmacy Enhanced Services Network (CPESN) in Missouri developed an initiative to enhance SDOH screening by utilizing community health workers to provide SDOH support.
Re-Hale , which is currently ongoing in collaboration with NHS Kent and Medway Integrated Care Board, has seen the introduction of an inhaler recycling scheme within the East Kent area to collect unwanted inhalers using local drop-off collection sites, including acute trusts, primary care and communitypharmacies. 2024; 85: 1-9.
But then our pharmacists began to be included in the vaccination programmes in countries where they never have been included before, such as France, but also in communitypharmacies, which before had only offered flu vaccinations like in Germany where it had been unthinkable that pharmacists would do that, as only doctors had the allowance.
The upcoming 2024 PQA Annual Meeting's poster session will showcase 23 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, this session offers authors a platform to exhibit their work and enables attendees to engage in insightful discussions about healthcare quality.
Graduating with a first-class BSc in pharmacy in 1999, he completed pre-registration training in communitypharmacy before returning to QUB School of Pharmacy for his PhD in pharmaceutics.
After finishing his degree here, he undertook his pre-registration in a busy communitypharmacy in a deprived area of east London. One of the most valuable lessons he learnt from this experience was the importance of communication. ‘As He has continued to strive to be the best at what he does ever since.
Rare disease pharmaceutical treatments require an additional layer of expertise of a specialty pharmacy, in addition to much greater staff education, patient and manufacturer interaction, and clinical coordination.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content